Late Breaking Abstract-PMG1015 demonstrates well-tolerated safety and favorable FVC changes after 12 weeks of treatment in IPF Patients
用户zCL_XFDWAdZs
2小时前
25
10
已关闭
DOI:
文献链接:
其他信息:
TM Maher, H Dai, C Wang, H Zhang, Q Luo, J Xu, J Bai…
2025
publications.ersnet.org
Background: Sustained Amphiregulin (AREG) expression from persistent intermediate
alveolar epithelial stem cells drives pulmonary fibrosis. PMG1015, a first-in-class antibody …
